Sponsored by:
Q&A on Large-Scale Commercial Expansion at Lonza's Stein Facility
Explore the Q&A to see how Lonza’s integrated network and proven tech transfer expertise (>50 projects in the past 12 months) can help you manufacture efficiently and bring therapies to market faster.
Lonza’s new large-scale facility in Stein, Switzerland, empowers you to simplify your supply chain and manufacture with confidence. With capabilities across vial, PFS, and cartridge formats, with a focus on GMP Annex-1 compliance, automation, and sustainability—integrated with our biologics drug substance global network.
Explore the Q&A to see how Lonza’s integrated network and proven tech transfer expertise (>50 projects in the past 12 months) can help you manufacture efficiently and bring therapies to market faster.
